Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026 and Sep 2026.
- Largest single sale: $485K (5,386 shares) of Tarsus Pharmaceuticals, Inc. on Sep 4, 2026. Filing
- Last sale before this period: Jun 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Jan 4, 2022 | Sep 9, 2026 |
| Staar Surgical Co (STAA) | Director | Jan 26, 2021 | Jun 20, 2025 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 4, 2026, Tarsus Pharmaceuticals, Inc.: sold 13,953 shares for $1.2M, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 2, 2026, Tarsus Pharmaceuticals, Inc.: sold 6,977 shares for $558K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 1, 2026, Tarsus Pharmaceuticals, Inc.: sold 4,601 shares for $340K, under a disclosed plan. 1 filing: 1
- Mar 19, 2026, Tarsus Pharmaceuticals, Inc.: sold 390 shares for $26K, to cover taxes. 1 filing: 1
- Mar 18, 2026, Tarsus Pharmaceuticals, Inc.: sold 379 shares for $26K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.